Macular Degeneration Medications in Connecticut — Compare Prices at Local Pharmacies
Connecticut residents managing macular degeneration face a wide range of medication choices — and an even wider range of prices. This page maps the macular degeneration treatment landscape in Connecticut: who's affected, which medications are most common, what state assistance exists, and where to find the lowest cash prices.
Connecticut Macular Degeneration Landscape
Macular Degeneration is one of the most-prescribed conditions in Connecticut. The state's pharmacy market includes major chains (CVS, Walgreens, Walmart, Costco) and a substantial independent pharmacy network — independents often have the lowest cash prices, but they're invisible to most coupon platforms. ConnPACE was discontinued in 2012. Connecticut residents should explore Medicare Extra Help, HUSKY Health, and manufacturer patient assistance programs.
Most Common Macular Degeneration Medications in Connecticut
Click any medication to see Connecticut pharmacy bids and cash-pay pricing.
Connecticut Resources for Macular Degeneration Patients
State-funded and state-recognised programs that may help offset macular degeneration medication costs.
Connecticut Board of Pharmacy: https://portal.ct.gov/DCP
Macular Degeneration Pricing by Connecticut City
Drill into city-level pharmacy bids for macular degeneration medications.
Free · no signup required · verified Connecticut pharmacies
Macular Degeneration in Connecticut — FAQ
What are the most common macular degeneration medications prescribed in Connecticut?+
Connecticut prescribers most commonly use Ranibizumab, Aflibercept, Bevacizumab for macular degeneration. Choice depends on patient factors — kidney function, other medications, insurance coverage and budget. Generic versions are widely stocked across Connecticut pharmacies; cash prices range widely, which is why comparing matters.
How many Connecticut residents have macular degeneration?+
Roughly 281,000 adults in Connecticut live with macular degeneration (national prevalence 11 million Americans applied to the state's adult population). With 5.7% of Connecticut adults uninsured, cash-pay pricing for macular degeneration medications is a major financial factor for many patients.
Does Connecticut Medicaid cover macular degeneration medications?+
Connecticut Medicaid covers most first-line macular degeneration medications, typically with a small copay ($1–4 for generics). Prior authorization may be required for newer brand-name drugs. If you don't qualify for Medicaid, manufacturer patient assistance programs and ScriptUnlock cash pricing are the next best options — often cheaper than insurance copays for generics.
Are macular degeneration medications cheaper at independent pharmacies in Connecticut?+
Frequently, yes. Independent pharmacies in Connecticut negotiate directly with regional wholesalers and don't carry the corporate overhead of chains. On ScriptUnlock, Connecticut independents bid against chains for your macular degeneration prescription — the winning bid is usually 15–35% below national average retail.
Can I get a 90-day supply of macular degeneration medication in Connecticut?+
Yes. Connecticut pharmacies routinely dispense 90-day supplies for stable, chronic macular degeneration medications. Cash pricing for 90-day fills is usually 10–20% cheaper per day than 30-day fills — fewer dispensing fees. Ask your prescriber to write the script for "90 days, 3 refills" to lock in the savings.